
Mirapex 0.375mg Tablet ER
Marketer
Boehringer Ingelheim
Salt Composition
Pramipexole (0.375mg)
Overview Mirapex 0.375mg Tablet ER
Ropinirole 0.375mg Extended-Release tablets manage Parkinson's disease symptoms and restless legs syndrome (characterized by an irresistible urge to move legs due to unpleasant sensations). This medication reduces excessive tremors by regulating movement. Administer Ropinirole 0.375mg ER with food, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection; never skip doses, and complete the entire treatment regimen. Discontinuation must be discussed with your doctor; abrupt cessation is inadvisable. Potential side effects include nausea, dry mouth, tiredness, visual disturbances, constipation, and swelling in the extremities. Drowsiness and dizziness are common; avoid driving or activities demanding concentration until the medication's effects are known. Report unusual mood shifts, heightened libido, compulsive gambling, or excessive spending to your physician immediately, as these can be serious.
Uses of Mirapex 0.375mg Tablet ER
Tremors and involuntary movements | Uncomfortable leg sensations and urges to move
Major Benefits of Mirapex 0.375mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or dividing it. Mirapex 0.375mg Extended-Release tablets should be administered with a meal.
Common Side effects of Mirapex 0.375mg Tablet ER:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Mirapex 0.375mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Mirapex 0.375mg Extended-Release tablet should be taken with a meal.
How Mirapex 0.375mg Tablet ER works:
Extended-release Mirapex tablets (0.375mg) function by replicating the effects of dopamine, a neurotransmitter crucial for regulating motor control within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Extended-release Pramipexole tablets (0.375mg) can induce increased sleepiness when combined with alcohol.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirapex tablets (0.375mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirapex tablets (0.375mg) are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant. Mirapex 0.375mg ER tablets reduce prolactin levels, potentially disrupting lactation.
DrivingUNSAFE
Extended-release Mirapex 0.375mg tablets can induce adverse reactions impacting driving capabilities. These tablets may cause hallucinations, involving perceptions of nonexistent sights, sounds, or sensations, thus potentially impairing driving skills.
KidneyCAUTION
Extended-release Mirapex tablets (0.375 mg) require careful administration for individuals with impaired kidney function. Dosage modification of this medication may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The extended-release Mirapex 0.375mg tablet is likely safe for individuals with hepatic impairment. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Mirapex 0.375mg Tablet ER :
Omit a missed dose of Mirapex 0.375mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirapex 0.375mg Tablet ER
| Label | Value |
|---|---|
| Type of Compound | Benzothiazole-based compound |
| Potential for Dependence | None. |
| Type of Medication | Nervous System |
| Mechanism of Action | Drugs that stimulate dopamine receptors |
